Central vision can fade slowly with age-related macular degeneration. Faces blur. Words smear on a page. A dark spot can sit ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . Dec. 5 is World Geographic Atrophy Day, a new initiative that seeks to empower individuals with this advanced ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye, and it marks the first of a three-part series on dry ...

People with macular degeneration and other forms of central vision loss can see details like text and faces with this device.

Both environmental factors (smoking, poor nutrition, etc.) and genetic factors contribute to the progression of AMD. In patients with bilateral AMD, only 54% were found to have symmetric disease, ...

The longest living vertebrate on Earth may have a thing or two to teach us about maintaining our eyesight into old age. New ...